The Buck Gets $3.5 Million to Conduct the First-Ever Clinical Trial of Ketone Supplementation to Treat and or Prevent Frailty
September 12, 2023
September 12, 2023
NOVATO, California, Sept. 12 -- The Buck Institute for Research in Aging issued the following news release:
The Buck Institute for Research on Aging has received a $3.5 million federal grant to lead the first-ever double-blind, randomized, placebo-controlled clinical trial to understand the effects of ketone ester supplementation on frailty, a condition which develops following age-related decline in multiple physiological systems. TAKEOFF (Targeting Aging with Ketone Ester in Older . . .
The Buck Institute for Research on Aging has received a $3.5 million federal grant to lead the first-ever double-blind, randomized, placebo-controlled clinical trial to understand the effects of ketone ester supplementation on frailty, a condition which develops following age-related decline in multiple physiological systems. TAKEOFF (Targeting Aging with Ketone Ester in Older . . .